Iron chelation in early Parkinson's disease
Lancet Neurol
.
2023 Apr;22(4):290-291.
doi: 10.1016/S1474-4422(23)00039-X.
Authors
Sonia Levi
1
,
Maria Antonietta Volonté
2
Affiliations
1
Vita-Salute San Raffaele University and San Raffaele Scientific Institute, Milan 20132, Italy. Electronic address: levi.sonia@hsr.it.
2
Neurology Department, San Raffaele Scientific Institute, Milan, Italy.
PMID:
36931794
DOI:
10.1016/S1474-4422(23)00039-X
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Humans
Iron Chelating Agents / therapeutic use
Parkinson Disease* / drug therapy
Substantia Nigra
Substances
Iron Chelating Agents